Kinoxis Therapeutics Pty Ltd.
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 1
- Market Cap
- -
A Phase 1 Study Investigating the Safety, Tolerability and Pharmacokinetics of KNX100 in Healthy Volunteers
- First Posted Date
- 2021-05-25
- Last Posted Date
- 2025-01-06
- Lead Sponsor
- Kinoxis Therapeutics Pty Ltd
- Target Recruit Count
- 57
- Registration Number
- NCT04901078
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Victoria, Australia
© Copyright 2025. All Rights Reserved by MedPath